Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:GRF
DateHeureSourceTitreSymboleSociété
18/04/202415h30GlobeNewswire Inc.Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.AMEX:GRFEagle Capital Growth Fund Inc
04/04/202410h00GlobeNewswire Inc.Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningAMEX:GRFEagle Capital Growth Fund Inc
07/03/202417h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:GRFEagle Capital Growth Fund Inc
06/03/202418h56Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportAMEX:GRFEagle Capital Growth Fund Inc
28/02/202417h20Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
23/02/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202409h16GlobeNewswire Inc.Grifols announces positive topline phase 3 fibrinogen clinical trial resultsAMEX:GRFEagle Capital Growth Fund Inc
13/02/202421h09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
27/12/202321h58Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]AMEX:GRFEagle Capital Growth Fund Inc
15/11/202314h00GlobeNewswire Inc.Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin DeficiencyAMEX:GRFEagle Capital Growth Fund Inc
06/11/202314h00GlobeNewswire Inc.GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023AMEX:GRFEagle Capital Growth Fund Inc
25/10/202300h30GlobeNewswire Inc.Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTADAMEX:GRFEagle Capital Growth Fund Inc
13/10/202323h30Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:GRFEagle Capital Growth Fund Inc
15/08/202321h45Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualAMEX:GRFEagle Capital Growth Fund Inc
01/08/202314h00GlobeNewswire Inc.Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and AnalyticsAMEX:GRFEagle Capital Growth Fund Inc
12/05/202319h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:GRFEagle Capital Growth Fund Inc
12/05/202318h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:GRFEagle Capital Growth Fund Inc
19/04/202321h25Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:GRFEagle Capital Growth Fund Inc
18/04/202316h30PR Newswire (US)Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023AMEX:GRFEagle Capital Growth Fund Inc
17/03/202314h40Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:GRFEagle Capital Growth Fund Inc
01/03/202312h42Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:GRFEagle Capital Growth Fund Inc
14/02/202318h38Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)AMEX:GRFEagle Capital Growth Fund Inc
27/12/202220h03Edgar (US Regulatory)Fidelity Bond Filed Pursuant to Rule 17g-1(g)(1) of the Investment Company Act of 1940 (40-17g)AMEX:GRFEagle Capital Growth Fund Inc
14/10/202223h00Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.37 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
23/08/202220h02Edgar (US Regulatory)Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)AMEX:GRFEagle Capital Growth Fund Inc
12/05/202215h53GlobeNewswire Inc.Deutsche Bank’s Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewingAMEX:GRFEagle Capital Growth Fund Inc
05/05/202214h58GlobeNewswire Inc.International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022AMEX:GRFEagle Capital Growth Fund Inc
01/04/202219h37Edgar (US Regulatory)Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)AMEX:GRFEagle Capital Growth Fund Inc
 Showing the most relevant articles for your search:AMEX:GRF